INOTROPE VERSUS PLACEBO THERAPY IN CARDIOGENIC SHOCK: THE CAPITAL DOREMI2 TRIAL
Simon Parlow(University of Ottawa), Rebecca Mathew(University of Ottawa), Emilie P. Belley‐Côté(McMaster University), Lynn Sterling, Z. Koopman(University of Ottawa), Laura Goodliffe(McMaster University), Richard G. Jung(University of Ottawa), Craig Ainsworth(McMaster University), Faizan Amin(McMaster University), Brent Morgan(Monash Health), Shannon M. Fernando(University of Ottawa), Pouya Motazedian(University of Ottawa), Pietro Di Santo(University of Ottawa), Benjamin Hibbert(Mayo Clinic)
Cited by 0
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|495